Phytochem Remedies IPO 2025: Subscription Update, Issue Details, and Key Highlights

Market Performance

The Phytochem Remedies IPO opened for subscription on December 18, 2025, aiming to raise ₹38.22 crore through a fresh issue of 0.39 crore shares. The maiden offering attracted initial investor interest, though demand remained modest on the first day. As the SME segment continues to draw attention, the IPO reflects growing activity among small and mid-cap investors seeking long-term opportunities in manufacturing-focused companies.

IPO Details: Phytochem Remedies

Phytochem Remedies is offering shares at a fixed price of ₹98 per share. Investors can apply in lots of 1,200 shares, with a minimum investment of ₹2,35,200 for two lots. The IPO will remain open until December 22, 2025.

Key allocation of IPO proceeds includes:

• ₹13.60 crore for machinery purchase
• ₹5.88 crore for civil construction
• ₹9.37 crore for repayment of borrowings
• Remaining funds for general corporate purposes

The allotment is scheduled for December 23, with listing on the BSE SME on December 26, 2025.

Subscription Status

On the first day of bidding, Phytochem Remedies' IPO recorded modest subscription levels:

• Overall subscription: 2%
• Retail portion: 3%
• Non-Institutional Investors (NII): 2%

Investors submitted bids for 91,200 shares against 37,03,200 shares on offer. The data indicates early interest, but the IPO still has room to attract additional participation before the closing date.

About Phytochem Remedies

Founded in 2002, Phytochem Remedies specializes in manufacturing corrugated boxes and board solutions. The company caters to multiple sectors, including food and beverage, FMCG, pharmaceuticals, pesticides, and the automotive industry. Operations are based across two units in Bari Brahmana, Jammu, highlighting a strong regional manufacturing presence.

Summary

Phytochem Remedies IPO offers investors an opportunity to participate in a niche manufacturing segment. While the first-day subscription was modest, the fixed price structure and allocation for operational expansion indicate a well-defined plan for growth. With the allotment scheduled for December 23 and listing on December 26, the IPO remains an attractive addition for those exploring SME market offerings.